Healthcare Industry - Medical - Pharmaceutical - Biotech in Boston, United States

The 5th Operationalize: Expanded Access Programs Summit in Boston on 18 Mar

The 5th Operationalize: Expanded Access Programs Summit

Boston   Tuesday, March 18, 2025   0900 - 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Expanded Access Programs (EAPs) are increasingly recognized as an ethical imperative in modern healthcare. More companies are opening EAPs to provide critical therapies to patients who would otherwise lack access. However, challenges persist, especially when navigati ..
TPD and Induced Proximity Pharma Partnering Summit in Boston on 19 May

TPD and Induced Proximity Pharma Partnering Summit

Boston   Monday, May 19, 2025   0730 - 1500
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Accelerate licensing and collaboration deals across TAC and Molecular Glue discovery platforms and pipelines to validate capabilities, improve tissue specificity of protein homeostasis, and leverage known, undruggable targets across diseases. URLs: Brochure: http ..
4th Circular and Self-Amplifying RNA Therapeutics Summit 2025 in Boston on 28 May

4th Circular and Self-Amplifying RNA Therapeutics Summit 2025

Boston   Wednesday, May 28, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-amplifying RNAs to provide improved stability, durability, longevity and ..
Pre-Filled Syringes and Injectable Drug Devices East Coast in Boston on 28 Apr

Pre-Filled Syringes and Injectable Drug Devices East Coast

Boston   Monday, April 28, 2025   0800 - 1740
Free
Healthcare Industry - Medical - Pharmaceutical - Biotech
NEW FOR 2025: FREE TO ATTEND FOR PHARMA AND BIOTECH* SAE Media Group's 12th Annual Pre-Filled Syringes and Injectable Drug Devices East Coast Conference and Exhibition will return to Boston in April 2025 to bring you the latest advances in the combination product ..
4th Annual ADC Analytical Development Summit in Boston on 28 Apr

4th Annual ADC Analytical Development Summit

Boston   Monday, April 28, 2025   0800 - 1545
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 4th ADC Analytical Development Summit is returning to Boston in April 2025. This event will bring together the brightest minds in the field to address the unique analytical challenges of antibody-drug conjugates. As regulatory expectations tighten and ADCs become ..
2nd Peptide-Based Therapeutics Summit in Boston on 1 Apr

2nd Peptide-Based Therapeutics Summit

Boston   Tuesday, April 1, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With Merck's oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J AND J's IL23R antagonist peptide continuing its phase 3 journey, and Chugai advancing peptides into the intracellular space, peptide therapeutics are firmly back on the map as the next mo ..
4th Cell Therapy Potency Assay Summit in Boston on 11 Mar

4th Cell Therapy Potency Assay Summit

Boston   Tuesday, March 11, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. With the field anticipating finalized regulatory guidelines from the FDA, the need to link mechanisms of action to potency assays scientifically has never been m ..
10th 3D Tissue Models Summit 2025 in Boston on 6 May

10th 3D Tissue Models Summit 2025

Boston   Tuesday, May 6, 2025   0900 - 1515
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Following the FDA's introduction of the Modernization Act 3.0 and the latest guidance on new approach methods (NAMs), GSK developing a new lung organoid model to empower pulmonary fibrosis research, and Merck acquiring HUB Organoids to enable more effective drug deve ..
Dark Genome Target Discovery and Development Summit in Boston on 16 Jun

Dark Genome Target Discovery and Development Summit

Boston   Monday, June 16, 2025   0800 - 1530
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the Inaugural Dark Genome Target Discovery and Development Summit The Dawn of the Dark Genome Has Arrived... Significant technological advances in computational biology, next-gen sequencing, -omics platforms and AI have unlocked the transformative po ..
4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit in Boston on 24 Jun

4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit

Boston   Tuesday, June 24, 2025   0800 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Lipid-based nanoparticles are evolving-faster, safer and more precise than ever. With traditional LNPs struggling to reach tissues beyond the liver, the industry is doubling down on next generation technologies for extra-hepatic. In 2024 alone, Novo Nordisk invested ..
3rd Obesity and Weight Loss Drug Development Summit in Boston on 14 Jul

3rd Obesity and Weight Loss Drug Development Summit

Boston   Monday, July 14, 2025   0800 - 1610
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 3rd Obesity and Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling the obesity epidemic. This year, we're evaluating the obesity landscape, diving deep into the game-changing potential of novel targets and ..
4th Annual LNP Formulation and Process Development Summit in Boston on 14 Apr

4th Annual LNP Formulation and Process Development Summit

Boston   Monday, April 14, 2025   0800 - 1700
2799.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload types, completely dominating the non-viral delivery field, the promise of this deliver ..
3rd Precision Medicine in Inflammatory Bowel Disease Summit | May 13-15, 2025 in Boston on 13 May

3rd Precision Medicine in Inflammatory Bowel Disease Summit | May 13-15, 2025

Boston   Tuesday, May 13, 2025   0800 - 1540
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 3rd Precision Medicine in Inflammatory Bowel Disease Summit Deliver Safe and Effective Precision Therapies to Every IBD Patient With fierce competition in clinical trials for Chron's Disease and Ulcerative Colitis following a year of exceptional pr ..
4th GPCRs-Targeted Drug Discovery Summit in Boston on 20 May

4th GPCRs-Targeted Drug Discovery Summit

Boston   Tuesday, May 20, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Transforming the Discovery of Novel GPCR-Targeted Therapies With positive clinical read outs by Tectonic Therapeutics and recent funding rounds for Confo Therapeutics and Septerna, the potential for novel GPCR drug classes to treat a plethora of diseases grows. No ..
2nd Structure-Based Drug Design Summit in Boston on 3 Jun

2nd Structure-Based Drug Design Summit

Boston   Tuesday, June 3, 2025   0900 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With tightening budgets and increasing pressure to de-risk R AND D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling technologies-from computational modeling and AI-driven predictions to ..
7th Annual Allogeneic Cell Therapies Summit in Boston on 10 Jun

7th Annual Allogeneic Cell Therapies Summit

Boston   Tuesday, June 10, 2025   0900 - 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable redu ..
3rd Gene Therapy Potency Assay Summit 2025 in Boston on 28 May

3rd Gene Therapy Potency Assay Summit 2025

Boston   Wednesday, May 28, 2025   0730 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
After a turbulent year in the gene therapy field, the 3rd Gene Therapy Potency Assay Summit returns at a time when drug developers are increasingly recognizing that it is business-critical to have a robust potency assay to support clinical and commercial progress. ..
7th Bacteriophage Therapy Summit in Boston on 11 Mar

7th Bacteriophage Therapy Summit

Boston   Tuesday, March 11, 2025   0800 - 1545
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
2024 has revitalized the bacteriophage field, with over $9 Million invested into BiomX and Locus Bioscience; $24 Million dedicated by BARDA to progress bacteriophage therapies to Phase II trials; and the release of further regulatory guidelines by agencies. The ad ..
6th Supply Chain and Logistics for Cell and Gene Therapies Summit in Boston on 11 Mar

6th Supply Chain and Logistics for Cell and Gene Therapies Summit

Boston   Tuesday, March 11, 2025   0900 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the cell and gene therapy (CGT) pipeline matures and new, exciting technologies scale into the clinic, the success of delivering the growing number of complex CGTs to patients in a safe and timely manner relies on robust and resilient global supply chains. Join ..
4th mRNA Analytical Development and Quality Control Summit in Boston on 25 Feb

4th mRNA Analytical Development and Quality Control Summit

Boston   Tuesday, February 25, 2025   0800 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With RNA technologies receiving the Nobel Prize two years running, we are witnessing the mRNA industry make great strides as optimized analytics, critical quality control methodology and robust assay development lead to efficient approvals and commercialization. Howe ..
Targeted Radiopharmaceuticals Target Selection and Drug Design Summit in Boston on 25 Feb

Targeted Radiopharmaceuticals Target Selection and Drug Design Summit

Boston   Tuesday, February 25, 2025   0900 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The radiopharmaceutical race is on and pharma leaders such as AstraZenca, BMS , Eli Lilly, Novartis and Sanofi are not getting left behind. Bolstering discovery pipelines through acquisitions of preclinical Mariana Oncology, Radionetics and Aktis Oncology, the field ..
7th CKD3 Summit 2025 in Boston on 17 Mar

7th CKD3 Summit 2025

Boston   Monday, March 17, 2025   0800 - 1800
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The transformative era of kidney drug development is here, with 2024 bringing landmark advancements, including Novartis' Borealis Biosciences and approvals in IgAN, Travere Therapeutics, and industry-defining acquisitions by Biogen and Vertex. Breakthrough therapies ..
13th Alzheimers and Parkinsons Drug Development Summit in Boston on 18 Mar

13th Alzheimers and Parkinsons Drug Development Summit

Boston   Tuesday, March 18, 2025   0830 - 1700
2999.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile s ..
6th TCR-Based Therapies Summit in Boston on 1 Apr

6th TCR-Based Therapies Summit

Boston   Tuesday, April 1, 2025   0800 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immatics, Triumvira, Affini-T, CDR-Life, and TScan, along with a wealth of investment and partnerships amounting to over $ ..
3rd Nasal Formulation and Delivery Summit in Boston on 1 Apr

3rd Nasal Formulation and Delivery Summit

Boston   Tuesday, April 1, 2025   0900 - 1500
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery or emergency use, nasal delivery is opening a new era of more efficient drug and vaccine ..
7th Treg-Directed Therapies Summit in Boston on 25 Mar

7th Treg-Directed Therapies Summit

Boston   Tuesday, March 25, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and Parvus and AbbVie, creating a surge of innovation and spotlighting Treg cell therapies an ..
4th Novel Conjugate Summit in Boston on 25 Mar

4th Novel Conjugate Summit

Boston   Tuesday, March 25, 2025   0900 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 4th Novel Conjugates Summit! We are witnessing a surging 83% growth of novel drug conjugates, with major collaborations between Nurix and Pfizer for antibody-degrader conjugates and Bicycle and Novartis for radiopharmaceuticals. With investments boo ..
8th Antigen-Specific Immune Tolerance Summit in Boston on 25 Feb

8th Antigen-Specific Immune Tolerance Summit

Boston   Tuesday, February 25, 2025   0800 - 1600
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Immune tolerance offers a transformative approach to autoimmune diseases treatment and holds the power to modify the course of disease progression and significantly improve the quality of life for patients. For 7 years, the 8th Antigen-Specific Immune Tolerance Su ..
2nd GLP-1-Based Therapeutics Summit 2025 in Boston on 29 Apr

2nd GLP-1-Based Therapeutics Summit 2025

Boston   Tuesday, April 29, 2025   0900 - 1535
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
It is no secret that GLP-1 receptor agonists have transformed the treatment of obesity and diabetes. The past 12 months have seen the GLP-1 landscape transform into something truly unrecognizable in previous years, with the global GLP-1 analogues market valued at US$ ..
8th Gene Therapy Development Summit 2025 in Boston on 25 Mar

8th Gene Therapy Development Summit 2025

Boston   Tuesday, March 25, 2025   0830 - 1715
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene therapy approvals in the last 18 months, billion-dollar collaborations, and the development of treatments for more common ..
Comprehensive Update in Nephrology - 2025 in Boston on 16 Mar

Comprehensive Update in Nephrology - 2025

Boston   Sunday, March 16, 2025   0800 - 1600
1255.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Updates, advances and practical information you can use now to screen, diagnose and manage patients with kidney disease With more than 50 interactive lectures and case-based sessions, this program provides a comprehensive update of the most important changes now imp ..
Cancer R&D World Conference 2025 (CRDWC 2025) in Boston on 10 Sep

Cancer R&D World Conference 2025 (CRDWC 2025)

Boston   Wednesday, September 10, 2025   0900 - 1700
599.00 GBP
Healthcare Industry - Medical - Pharmaceutical - Biotech
Precision Global Conference cordially invites you to our Cancer R&D World Conference (CRDWC 2025) HYBRID EVENT, Which Will Be Held from 10 to 12 September 2025 in Boston, Massachusetts, USA. Conference theme: “Innovating Cancer Care: Pioneering Research and Develop ..
3rd Retinal Imaging Biomarkers and Endpoints Summit in Boston on 27 May

3rd Retinal Imaging Biomarkers and Endpoints Summit

Boston   Tuesday, May 27, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Accelerate Your Ophthalmic Development with Deep Learning Systems and Sophisticated AI Imaging Technologies... With state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with ..
4th In Vivo Cell Engineering and Gene Editing Summit in Boston on 3 Jun

4th In Vivo Cell Engineering and Gene Editing Summit

Boston   Tuesday, June 3, 2025   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 4th In Vivo Cell Engineering and Gene Editing Summit, the premier event dedicated to enhancing the next frontier of in vivo cell and gene approaches from research to clinic. This summit provides you with exclusive insights into the latest IND enabling ..
2nd Measuring Patient Engagement Summit in Boston on 29 Apr

2nd Measuring Patient Engagement Summit

Boston   Tuesday, April 29, 2025   0900 - 1700
2599.00 GBP
Healthcare Industry - Medical - Pharmaceutical - Biotech
Understanding the patient's perspective is essential to driving the success of clinical trials, accelerating regulatory approvals, and enhancing the patient experience throughout their healthcare journey. Yet, amidst a challenging funding environment, empowered patie ..
3rd Viral Vector Process Development and Manufacturing Summit in Boston on 19 Feb

3rd Viral Vector Process Development and Manufacturing Summit

Boston   Wednesday, February 19, 2025   0900 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 3rd Viral Vector Process Development and Manufacturing Summit Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leade ..
2nd Annual Protein Degradation for CNS Summit in Boston on 18 Feb

2nd Annual Protein Degradation for CNS Summit

Boston   Tuesday, February 18, 2025   0900 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Protein Degradation for CNS Summit returns to Boston for its 2nd year running. With this ever-progressing field in neurodegenerative disease drug development, the design of protein degradation therapies has gained huge amounts of momentum. With the first patient ..
Neuroscience Innovation Pharma Partnering Summit in Boston on 18 Feb

Neuroscience Innovation Pharma Partnering Summit

Boston   Tuesday, February 18, 2025   0800 - 1700
2399.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Accelerate collaboration and partnering across neurology and psychiatry pipelines and technologies, to reduce risk, validate technologies, and deliver better biodistribution of safe and efficacious molecules to the CNS URLs: Brochure: https://go.evvnt.com/27580 ..
Proteomic Based Drug Discovery Summit 2025 in Boston on 11 Feb

Proteomic Based Drug Discovery Summit 2025

Boston   Tuesday, February 11, 2025   0830 - 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Proteomics offers huge advantages for the discovery and pre-clinical development of small molecule drugs and their translation into robust clinical candidates. Just this year, Sanofi has dedicated $700M to Belharra Therapeutics to develop a proteomics platform and Ga ..
3rd Kinase Targeted Drug Discovery Summit in Boston on 11 Feb

3rd Kinase Targeted Drug Discovery Summit

Boston   Tuesday, February 11, 2025   0730 - 1445
0.50 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Propel Kinase Biology Understanding to Increase Selectivity, Overcome Resistance and Find the Optimal Combination Partner to Develop Best and First-in-Class Kinase Targeted Drugs The kinase drug discovery field is at a pivotal moment, with recent breakthroughs fro ..
8th DDR Inhibitors Summit 2025 in Boston on 28 Jan

8th DDR Inhibitors Summit 2025

Boston   Tuesday, January 28, 2025   0830 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Making Strides in Targeting PARP, ATR, ATM, WEE1 and POLθ AstraZeneca and Merck are at the forefront of DDR inhibitor development, focusing on next-generation PARP inhibitors and innovative combination therapies. At the same time, Roche and Novartis are pushing th ..
3rd Molecular Glue Drug Development Summit in Cambridge on 28 Jan

3rd Molecular Glue Drug Development Summit

Cambridge   Tuesday, January 28, 2025   0800 - 1645
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Molecular glue development continues to thrive, offering exciting opportunities to target previously undruggable proteins and treat a wide range of diseases. 2024 has seen a multitude of collaborations, with Takeda and Degron Therapeutics entering a deal worth $1.2 b ..
6th RNAi-Based Therapeutics Summit in Boston on 28 Jan

6th RNAi-Based Therapeutics Summit

Boston   Tuesday, January 28, 2025   0800 - 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As innovative drug delivery platforms beyond GalNac continue to emerge and novel chemical modifications are discovered, the potential for RNAi therapeutics to treat a plethora of diseases grows. Now more than ever, RNAi therapies hold promise to treat diseases beyond ..
2nd Covalent Drug Discovery and Development Summit in Boston on 10 Dec

2nd Covalent Drug Discovery and Development Summit

Boston   Tuesday, December 10, 2024   0900 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs With continued advancements in screening platforms and proteomics, the covalency renaissance continues as biopharma race to unlock ..
8th Complement-based Drug Development Summit in Boston on 10 Dec

8th Complement-based Drug Development Summit

Boston   Tuesday, December 10, 2024   0900 - 1800
2931.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors The complement community is shifting gear, with more companies than ever targeting alternative complement proteins for their therapies, allowing for a larger range of diseases to be ta ..
Patient Recruitment for Rare Disease Trials Summit 2024 in Boston on 10 Dec

Patient Recruitment for Rare Disease Trials Summit 2024

Boston   Tuesday, December 10, 2024   0800 - 1700
2999.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
In the face of unprecedented cost-per-patient expenses, the FDA's recent focus on rare disease, and a myriad of options for identifying, engaging, screening, and retaining eligible patients, it is essential to prioritize patient-centric recruitment strategies. As the ..
2nd Capital Project Engineering in Pharma Summit in Boston on 4 Dec

2nd Capital Project Engineering in Pharma Summit

Boston   Wednesday, December 4, 2024   0900 - 1630
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Join 80+ CapEx, Construction and Engineering professionals from leading pharma, biotech, CDMO and medtech companies across to the United Stated to tackle the following issues head on: - Optimizing risk management - Enhancing supply chain collaboration - Scaling re ..
6th Cell Therapy Analytical Development Summit 2024 in Boston on 3 Dec

6th Cell Therapy Analytical Development Summit 2024

Boston   Tuesday, December 3, 2024   0800 - 1735
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Demonstrating your cell therapy's superior safety and efficacy is vital for standing out in a competitive market and attracting investment. Integrating cutting-edge technologies and robust analytical methods is key to showcasing your product's strengths and securing ..
4th iPSC Drug Development and Manufacturing Summit in Boston on 1 Oct

4th iPSC Drug Development and Manufacturing Summit

Boston   Tuesday, October 1, 2024   0800 - 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment. The 4th iPSC Drug Development and ..
8th MASH Drug Development Summit in Boston on 24 Sep

8th MASH Drug Development Summit

Boston   Tuesday, September 24, 2024   0800 - 1615
2999.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in Phase 1, 2, and 3 clinical trials. Paired with t ..

  •    
  •